INVO BioScience, Inc. - Common Stock (INVO)
0.8330
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 3rd, 12:21 PM EDT

Via Benzinga · October 16, 2024

INVO BioScience shares soared Monday after the company announced it has closed its merger with NAYA Biosciences. Here's what to know.
Via Benzinga · October 14, 2024

Via Benzinga · October 14, 2024

Via Benzinga · October 14, 2024

INVO Bioscience just reported results for the second quarter of 2024.
Via InvestorPlace · August 14, 2024

INVO Bioscience just reported results for the first quarter of 2024.
Via InvestorPlace · May 15, 2024

Via Benzinga · July 30, 2024

Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning!
Via InvestorPlace · July 29, 2024

Via Benzinga · July 29, 2024

Via Benzinga · May 15, 2024

Via Benzinga · May 14, 2024

Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Tuesday morning!
Via InvestorPlace · May 14, 2024

Via Benzinga · May 14, 2024

Via Benzinga · April 25, 2024

Via Benzinga · April 19, 2024

Friday is here and we're breaking down the biggest pre-market stock movers that traders need to know about this morning!
Via InvestorPlace · April 19, 2024

Via Benzinga · April 18, 2024

Via Benzinga · April 18, 2024

Via Benzinga · April 17, 2024

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The Dow traded up 0.04% to 37,813.77 while the NASDAQ fell 0.78% to 15,742.21. The S&P 500 also fell, dropping, 0.34% to 5,034.17.
Via Benzinga · April 17, 2024

U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.32% to 37,678.27 while the NASDAQ fell 1.16% to 15,681.95. The S&P 500 also fell, dropping, 0.74% to 5,013.98.
Via Benzinga · April 17, 2024

Via Benzinga · April 17, 2024

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.
Via Benzinga · April 17, 2024

Invo Bioscience reported $1.38 million in quarterly sales, representing a 396.15% increase over sales of $278,140 from the same period last year. The company also said it remains on-track with its goal of reaching break-even or profitability within its current operations in 2024.
Via Benzinga · April 17, 2024